Rappel de Mirage, Silverspeed, X-celerator & X-pedion Guidewires, Hyperform & Hyperglide Occlusion Balloon Catheters and Guidewires (Supplied in Procedure Packs)

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par EV3 Australia Pty Limited.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
  • ID de l'événement
  • Classe de risque de l'événement
    Class II
  • Date de mise en oeuvre de l'événement
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    There is a regulatory compliance issue where the guidewires were included in the australian register of therapeutic goods (artg) as class iia medical device. they should have been included as class iii. the hyperform and hyperglide occlusion balloon catheters, which are currently supplied in procedure packs also contain one of the above-mentioned guidewires. it has come to the attention of ev3 that these systems have not been included in the artg.
  • Action
    Quarantine affected stock. The use of affected microcatheters should be only limited to patients eligible under the Special Access Scheme.


  • Modèle / numéro de série
    Mirage, Silverspeed, X-celerator & X-pedion Guidewires, Hyperform & Hyperglide Occlusion Balloon Catheters and Guidewires (Supplied in Procedure Packs)
  • Manufacturer


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source